Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 00845275000863, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company LLC ,a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA --- For determination of Fibrinogen Degradation products in serum and urine.
Published August 2, 2017 · Recall initiated: May 19, 2017
Summary
FDA records medical device Class II recall Z-2762-2017, published August 2, 2017 and initiated May 19, 2017. Recalling firm: Fisher Diagnostics; Status: Terminated; Reported quantity: 331 units; Lot: Lot Number 948546, Exp. 9/30/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fisher Diagnostics
- Distributor
- USA (nationwide) including Puerto Rico, and Internationally to Colombia
- Lot
- Lot Number 948546, Exp. 9/30/2017
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factorApril 9, 2025
- FDAAtrium iCAST Balloon Expandable Covered Stent; 7mm x 22mm x 120cm; Model/Part Number 85455 (Marketed in U.S.August 2, 2017
- FDADLP Antegrade/Retrograde Adapter Method for perfusion of cardioplegia alternately in either an antegrade orAugust 2, 2017
- FDASmiths Medical CADD Blue-Striped IV Administration Set, REF 21-7036-01, Sterilized using ethylene oxide.August 2, 2017
- FDADLP Cardioplegia Adapter with Pressure Port Provides access for a pressure monitoring needle near theAugust 2, 2017
- FDAConverters(R) Tiburon(R) Arthroscopy Drape, REF 9414, STERILE EO, Qty. 1, Cardinal Health, Waukegan, IL AAugust 2, 2017
Questions about this recall
Was Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 00845275000863, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company LLC ,a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA --- For determination of Fibrinogen Degradation products in serum and urine. recalled?
Yes. FDA published recall Z-2762-2017 on August 2, 2017. Reported hazard: An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.
What should I do if I have this product?
Voluntary: Firm initiated · Letter